Medical Collagen Market Analysis, Size, and Share by 2028
Historic Data: 2018-2019 | Base Year: 2020 | Forecast Period: 2021-2028Medical Collagen Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Bovine, Porcine, and Others), Product (Gelatine, Hydrolysed Collagen, Native Collagen, and Others), and Application (Wound Care, Bone Grafts, Tissue Scaffolds, Cartilage Repair, Haemostats, Diagnostics, Vascular Grafts, and Others)
- Report Date : Apr 2021
- Report Code : TIPRE00012952
- Category : Life Sciences
- Status : Published
- Available Report Formats :

- No. of Pages : 172
The medical collagen market is expected to reach US$ 957.4 million by 2028 from US$ 593.7 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.
Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is a biocompatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. It is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. The growth of the medical collagen market is attributed to the factors such as the rising applications of collagen in the medical industry, and growing FDA approvals and product launches. However, product recalls hinder the market growth.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Medical Collagen Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Rising Applications of Collagen in Medical Industry
Collagen is the protein found in connective tissues of the body. It is the most abundant protein found in the mammals, which makes up around 25%–35% of the whole-body protein content. As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications.
The cardiac extracellular matrix (ECM) consists of fibrillar collagen that provides a means of force transmission, preserves myocardial integrity, and supports myocyte geometry. Several studies have proved that consuming collagen supplements will help in reducing the risk of heart-related conditions.
Collagen is one of the key constituents in cosmetic formulations as it has moisturizing, regenerating, and film-forming properties. Collagen has excellent ability to bind water that helps in maintaining proper water content in the skin throughout the day, which makes the skin moisturized and softened. Moreover, collagen fillers are widely used in aesthetic medicine. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing its dermatological defects.
Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes of spine, extremities, and dental. Further, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair.
Collagen is naturally involved in the wound-healing process and the use of collagen-based wound dressings offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound, by either absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds.
These wide range of applications of collagen in the medical industry favors the growth of the market.
Product-based Insights
The medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020, and it is anticipated to register the highest CAGR in the market during the forecast period.
Product-based Insights
Based on product, the medical collagen market is segmented into gelatine, hydrolysed collagen, native collagen, and others. The gelatine segment held the largest market share in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.
Application-based Insights
Based on application, the medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the medical collagen market players to enlarge customer base worldwide, which, in turn, permits them to maintain their brand name globally.
Medical Collagen Market Regional InsightsThe regional trends and factors influencing the Medical Collagen Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Medical Collagen Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Medical Collagen Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 593.7 Million |
| Market Size by 2028 | US$ 957.4 Million |
| Global CAGR (2020 - 2028) | 6.2% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Source
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
Medical Collagen Market Players Density: Understanding Its Impact on Business Dynamics
The Medical Collagen Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
- Get the Medical Collagen Market top key players overview
Medical Collagen Market – by Source
- Bovine
- Porcine
- Others
Medical Collagen Market – by Product
- Gelatine
- Hydrolysed Collagen
- Native Collagen
- Others
Medical Collagen Market – by Application
- Wound Care
- Bone Grafts
- Tissue Scaffolds
- Cartilage Repair
- Haemostats
- Diagnostics
- Vascular Grafts
- Other
Medical Collagen Market – by Geography
-
North America
- US
- Canada
- Mexico
-
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
-
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
-
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
-
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- DSM
- Integra Lifesciences Corporation
- Collagen Matrix Inc.
- Encoll
- Collagen Solutions Plc
- Innocoll
- Symatese
- Gelita AG
- Collplant Biotechnologies Ltd
- Croda Interntional PLC.
Frequently Asked Questions
Who are the major players in the medical collagen market?
What is medical collagen?
What are the driving factors for the medical collagen market across the globe?
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Related Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample For